Recently Kevin Price, Host of the nationally syndicated Price of Business Show, interviewed David Hale of Guebert Corp.
Background from Guebert:
“Since 1926, the Guerbet Group has had a long-standing tradition as a pioneer in the research and development of medical imaging contrast media. Headquartered in Paris, France, Guerbet is a publicly traded company holding more than 25% of the European market share and 7% of the worldwide contrast media market.
Guerbet makes full use of its know-how and innovative capacity to meet the major public health challenges of the 21st century.
“Our teams contribute to progress made in the diagnosis of major disease areas (cancer, cardiovascular, inflammatory and neurodegenerative diseases). Our novel and effective imaging solutions improve patient management throughout the world.”
The Price of Business is one of the longest shows of its kind in the country and is in markets coast to coast. The Host, Kevin Price, is a multi-award winning author, broadcast journalist, and syndicated columnist. Learn more about the show and its digital partners at www.PriceofBusiness.com (scroll down to the bottom of the page).
